Pharma Industry News Weekly Recap: January 27, 2023
// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target [...]
// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target [...]
// Biotech and Pharma Therapeutics AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets [...]
// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV specialist's [...]
// Biotech and Pharma Therapeutics Drug companies set sights on new Covid medicines to boost depleted arsenal December [...]
// Biotech and Pharma Therapeutics Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M [...]
// Biotech and Pharma Therapeutics A San Diego startup sees covalent biologics as the next frontier in cancer [...]
// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, [...]
// Biotech and Pharma Therapeutics Adamis, Harpoon, Neoleukin and Tricida add to biotech layoff wave as pipeline setbacks [...]
// Biotech and Pharma Therapeutics Early data hint at benefit for Amgen’s obesity drug November 8, 2022 / [...]
// Biotech and Pharma Therapeutics Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo [...]